Long-Term Management of Breast Cancer Bone Metastases: Two Case Reports
Patients with advanced HR+/HER2− breast cancer often experience prolonged disease courses, with bone being a dominant site of metastasis. Bone-targeted agents (BTAs) are recommended to reduce the risk of skeletal-related events (SREs), yet most clinical trials report follow-up durations of less than...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2025-01-01
|
| Colecção: | International Journal of Breast Cancer |
| Acesso em linha: | http://dx.doi.org/10.1155/ijbc/9601887 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|